Epidermal growth factor receptor (EGFR) inhibitors in cancer therapy

Prog Drug Res. 2005:63:93-114. doi: 10.1007/3-7643-7414-4_5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Cetuximab
  • Clinical Trials as Topic
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / physiology
  • Erlotinib Hydrochloride
  • Gefitinib
  • Humans
  • Neoplasms / drug therapy*
  • Quinazolines / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors
  • Cetuximab
  • Gefitinib